Hair Regrowth Protocol

Overview

Hair loss is a multifactorial condition driven by genetic predisposition, hormonal signaling (primarily dihydrotestosterone or DHT in androgenetic alopecia), inflammation, reduced blood supply to the follicle, and impaired stem cell signaling in the hair bulge region. The hair growth cycle consists of three phases: anagen (active growth, 2–7 years), catagen (transition, 2–3 weeks), and telogen (resting/shedding, 3 months). In pattern hair loss, the anagen phase progressively shortens while telogen extends, resulting in finer, shorter hairs until the follicle eventually miniaturizes.

Peptide-based hair regrowth protocols aim to address several of these mechanisms simultaneously — promoting angiogenesis around the follicle, reducing perifollicular inflammation, stimulating stem cell activity in the bulge, and supporting dermal papilla cell function. The two primary peptides used in this context are TB-500 and GHK-Cu, both of which have mechanisms relevant to follicular biology.

This protocol emphasizes topical application as the primary delivery method, with optional systemic support via subcutaneous injection.

Compounds Involved

GHK-Cu for Hair

GHK-Cu has been studied for its effects on hair follicle biology through several mechanisms. Research has shown that GHK-Cu can stimulate hair follicle growth in organ culture models, increase follicle size and hair shaft diameter, activate the Wnt/beta-catenin signaling pathway (which is critical for hair follicle stem cell activity), promote angiogenesis around the follicle, and increase expression of genes involved in the anagen (growth) phase.

Commercially, GHK-Cu has been incorporated into hair care products since the 1990s, and its effects on hair density have been observed in clinical studies of wound healing (where increased hair growth was noted as a secondary finding).

TB-500 for Hair

TB-500 (Thymosin Beta-4) has been identified as a key factor in hair follicle stem cell activation. Research published in peer-reviewed journals demonstrated that Thymosin Beta-4 promotes hair growth by activating progenitor cells in the hair follicle bulge — the reservoir of stem cells responsible for initiating new growth cycles. TB-500 also promotes angiogenesis, which improves blood supply to the follicle, and reduces inflammation that can contribute to follicular miniaturization.

Protocol Structure

Topical Protocol (Primary Approach)

Topical application delivers peptides directly to the scalp, creating high local concentrations at the follicular level.

GHK-Cu topical:

• Formulation: 1–2% GHK-Cu solution or serum
• Application: Apply to areas of thinning hair using a dropper or spray applicator
• Frequency: Once or twice daily
• Technique: Part hair to expose scalp, apply solution directly to scalp skin, gently massage in for 1–2 minutes
• Leave-on time: Minimum 4 hours before washing (overnight application is ideal)

TB-500 topical:

• Formulation: Reconstituted TB-500 in a carrier solution (typically 50–100 mcg/mL)
• Application: Apply to thinning areas
• Frequency: Once daily
• Technique: Same as GHK-Cu — apply to exposed scalp, gentle massage
• Timing: Can be applied at a different time of day than GHK-Cu, or mixed into the same application

Topical Preparation

For detailed preparation guidance, see Topical Application. Basic approaches:

1. Commercial formulations: Pre-made GHK-Cu serums are available and offer convenience and consistent concentration
2. Custom solutions: Reconstituted peptide dissolved in a suitable carrier (distilled water with a penetration enhancer like DMSO at 5–10% or hyaluronic acid serum as a base)
3. Microneedling enhancement: Dermarolling (0.5–1.0 mm needle depth) before peptide application significantly increases transdermal absorption. Microneedle once weekly, apply peptides immediately after

Systemic Support Protocol (Optional)

Adding subcutaneous injections provides systemic support alongside topical application:

TB-500 (SubQ):

• Loading: 2–5 mg, twice weekly for 4 weeks
• Maintenance: 2 mg, once weekly for 8 additional weeks

GHK-Cu (SubQ):

• Dose: 1–2 mg per day
• Duration: 8–12 weeks

Combined Protocol Timeline

Microneedling Protocol

Microneedling (dermarolling) is a significant adjunct to topical peptide application for hair regrowth:

Parameters:

• Needle depth: 0.5–1.0 mm (1.0 mm for scalp is most commonly referenced in research)
• Frequency: Once per week (not more — the scalp needs time to heal between sessions)
• Device: Dermaroller or dermapen with sterile, single-use cartridges
• Technique: Roll in multiple directions across thinning areas with moderate pressure

Integration with peptides:

1. Microneedle the target area
2. Immediately apply GHK-Cu and/or TB-500 topical solution to the needled area
3. Do not wash hair for at least 4 hours (overnight is preferred)
4. On non-microneedling days, apply peptides topically as usual

Important: Use sterile technique. Clean the scalp with alcohol before microneedling, and use only sterile needles. The micro-channels created by needling allow both increased peptide absorption and potential pathogen entry.

Realistic Expectations and Timeline

Hair regrowth is one of the slowest peptide-related outcomes due to the hair growth cycle:

Key point: A single hair growth cycle takes 4–7 months minimum. Meaningful cosmetic results require sustained use over multiple growth cycles. Discontinuing the protocol typically results in gradual return to the pre-treatment trajectory.

Complementary Approaches

• Minoxidil: The established topical vasodilator can be used alongside peptide topicals (apply at different times of day to avoid interaction)
• Finasteride/Dutasteride: DHT blockers address the hormonal driver of androgenetic alopecia. Peptides complement but do not replace anti-androgen therapy for hormonal hair loss
• Red light therapy (LLLT): Low-level laser therapy (650–670 nm) has evidence for stimulating hair growth and can be combined with this protocol
• Scalp massage: 5–10 minutes daily may improve local blood flow
• Nutritional support: Iron (if deficient), biotin, zinc, vitamin D, and omega-3 fatty acids support healthy hair growth

Important Considerations

• Type of hair loss matters: This protocol is most relevant for androgenetic alopecia and telogen effluvium. Alopecia areata (autoimmune) and cicatricial (scarring) alopecias involve different mechanisms and may require medical management. See Immune Support Protocol for autoimmune considerations.
• Gender considerations: Both male and female pattern hair loss may respond to this protocol, though the patterns and hormonal drivers differ.
• Follicle viability: Peptides cannot regrow hair from completely dead follicles. Areas that have been bald for many years with smooth, shiny scalp may have undergone irreversible follicular death. The best outcomes are seen in areas with miniaturized but still-viable follicles.
• Consistency is non-negotiable: Sporadic application will not produce results. Daily topical use for 6–12 months minimum is the standard commitment.
• Photography for tracking: Take standardized photos (same lighting, angle, wet hair) monthly to objectively assess progress, as daily changes are too subtle to perceive.

Disclaimer

This article is for educational and informational purposes only. It does not constitute medical advice, and no therapeutic claims are made. Peptide research is ongoing, and individual outcomes may vary. Consult a qualified healthcare professional before beginning any peptide protocol. All compounds discussed are intended for research purposes.